Terra Alpha Investments LLC Raises Position in Danaher Corporation $DHR

Terra Alpha Investments LLC increased its holdings in Danaher Corporation (NYSE:DHR) by 9.9% during the second quarter, HoldingsChannel reports. The institutional investor owned 15,759 shares of the conglomerate’s stock after acquiring an additional 1,421 shares during the quarter. Danaher comprises 3.2% of Terra Alpha Investments LLC’s investment portfolio, making the stock its 14th biggest position. Terra Alpha Investments LLC’s holdings in Danaher were worth $3,113,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. GHP Investment Advisors Inc. raised its position in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC raised its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC raised its position in Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher during the first quarter valued at about $31,000. Finally, Ramirez Asset Management Inc. purchased a new stake in Danaher during the second quarter valued at about $40,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 6.1%

DHR opened at $221.13 on Wednesday. The company has a market cap of $158.34 billion, a P/E ratio of 47.05, a P/E/G ratio of 3.01 and a beta of 0.77. The business’s 50-day moving average price is $202.07 and its 200-day moving average price is $197.59. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $269.24.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Bank of America lowered their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Evercore ISI raised their price target on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Rothschild Redb downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Finally, Rothschild & Co Redburn restated a “neutral” rating and set a $220.00 price target (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $245.00.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.